Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism

Pharmacogenetics and Genomics
Steven N HartXiao-bo Zhong


Cytochrome P450 oxidoreductase (POR) is the only flavoprotein that donates electrons to all microsomal P450 enzymes, which catalyze the biosynthesis of steroids, fatty acids, and bile acids, as well as metabolism of more than 80% of prescription drugs. Although mutations in POR have been identified in several disease states with disordered steroidogenesis, effects of polymorphisms on drug metabolism in the general population are unclear. In this report, we performed a comprehensive study to correlate POR polymorphisms with POR gene expression, POR activity, and P450-catalyzed drug metabolism. A set of human liver samples (n=99) were used in this study. POR polymorphisms were identified by sequencing the exons and surrounding introns of the POR gene and mRNA levels were quantified by branched DNA technology. POR activity was quantified by measuring cytochrome c reduction in liver microsomes and activities of 10 drug-metabolizing P450 enzymes were quantified by high performance liquid chromatography methods with drugs known to be specific for each enzyme. Of the 34 polymorphisms identified in this cohort, four polymorphisms changed an amino acid: K49N, L420M, A503V, and L577P. L577P likely resulted in an alpha helix change, possi...Continue Reading


Feb 16, 1972·Biochemical and Biophysical Research Communications·A Y Lu, W Levin
Mar 1, 1970·Journal of Molecular Biology·S B Needleman, C D Wunsch
Jul 15, 1996·Archives of Biochemistry and Biophysics·R E PearceAndrew Parkinson
Aug 5, 1997·Proceedings of the National Academy of Sciences of the United States of America·M WangJ J Kim
Oct 16, 1999·Science·William E Evans, M V Relling
Jan 14, 2000·Journal of Medical Genetics·William ReardonR M Winter
Oct 4, 2000·Journal of Medical Genetics·M J ParkerA C Davis
Aug 17, 2002·Science·Hai YanKenneth W Kinzler
Sep 10, 2002·Bioinformatics·Christophe LambertEric Depiereux
Nov 12, 2002·Methods in Enzymology·Maciej CzerwinskiAndrew Parkinson
Feb 5, 2003·The Journal of Biological Chemistry·Colin J HendersonC Roland Wolf
Mar 6, 2003·Genome Research·José Manuel Peregrin-AlvarezChristos A Ouzounis
Jul 9, 2004·Drug Metabolism Reviews·F Peter Guengerich
Oct 23, 2004·Drug Metabolism and Pharmacokinetics·Shogo OzawaJun-Ichi Sawada
Dec 8, 2004·Current Topics in Medicinal Chemistry·Ann K Daly
Jan 18, 2006·Annual Review of Medicine·Michel EichelbaumWilliam E Evans
Feb 24, 2006·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jing-Fen HanJun-Yan Hong
Apr 4, 2006·Clinical Pharmacology and Therapeutics·Jatinder LambaErin Schuetz
Aug 18, 2006·Current Opinion in Pediatrics·Christa E Flück, Walter L Miller
Sep 9, 2006·Molecular Interventions·Allan E Rettie, Guoying Tai
Sep 20, 2006·The Pharmacogenomics Journal·M Wadelius, M Pirmohamed
Sep 26, 2006·The Journal of Biological Chemistry·Christopher C MarohnicBettie Sue Masters
Oct 26, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Shou-Lin WangJun-Yan Hong
Jan 17, 2007·Clinical Endocrinology·Nils KroneWiebke Arlt
Apr 10, 2007·International Journal of Clinical Pharmacology and Therapeutics·S PadolR H Hunt
Sep 11, 2007·Drug Metabolism and Pharmacokinetics·Steven N HartXiao-bo Zhong
Feb 5, 2008·Pharmacogenomics·Hector C Keun, Toby J Athersuch


Mar 21, 2009·Pharmacogenetics and Genomics·Gary E SwanNeal L Benowitz
Jun 19, 2009·Pharmacogenetics and Genomics·Sarah C SimMagnus Ingelman-Sundberg
Aug 11, 2010·Pharmacogenetics and Genomics·Vishal AgrawalWalter L Miller
Nov 4, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Christopher C MarohnicMichel Kranendonk
May 13, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xiuling ZhangLaurence S Kaminsky
Jan 19, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Daniela MoutinhoMichel Kranendonk
Sep 17, 2010·European Journal of Endocrinology·Dorota Tomalik-ScharteWiebke Arlt
Dec 17, 2009·European Journal of Clinical Pharmacology·Nael Al KoudsiRachel F Tyndale
Jan 20, 2009·Journal of Neurogenetics·Gary E Swan, Christina N Lessov-Schlaggar
Apr 25, 2008·Expert Opinion on Drug Metabolism & Toxicology·Steven N Hart, Xiao-bo Zhong
Dec 19, 2015·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Timothy S TracyYvonne S Lin
Jan 29, 2013·Pharmacology & Therapeutics·Amit V Pandey, Christa E Flück
Aug 25, 2010·Biochemical and Biophysical Research Communications·Amit V PandeyPrimus E Mullis
Mar 2, 2010·Molecular and Cellular Endocrinology·Catherine NicoloAmit V Pandey
Aug 17, 2011·Biochemical and Biophysical Research Communications·Christa E FlückAmit V Pandey
Jun 13, 2015·Pharmacogenomics·Rebecca A PulkDeKAF Investigators
Feb 26, 2015·Pharmacogenomics·Mária TomkováPavel Martásek
Jun 9, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hai-Feng ZhangHai-Ling Qiao
Oct 13, 2016·Genomics, Proteomics & Bioinformatics·Shabbir AhmedShu-Qing Chen
Oct 5, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xian PanHyunyoung Jeong
Oct 27, 2017·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Tianran SongHaixiang Sun
Nov 10, 2017·PloS One·Ibrahim El-SerafiMoustapha Hassan
Jun 30, 2018·Drug Metabolism Reviews·S Cyrus KhojastehIvonne M C M Rietjens
Jan 24, 2009·Journal for Specialists in Pediatric Nursing : JSPN·Martha Driessnack
Jun 14, 2008·Pharmacogenetics and Genomics·Vishal AgrawalWalter L Miller
Oct 11, 2012·Pharmacogenetics and Genomics·Lei HuLan Fan
Oct 2, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Lai PengXiao-bo Zhong
Jan 20, 2018·Journal of Child and Adolescent Psychiatric Nursing : Official Publication of the Association of Child and Adolescent Psychiatric Nurses, Inc·Michaela K Hogan, Nikhil P Rao
Sep 6, 2017·Drug Metabolism and Personalized Therapy·Janthima MethaneethornThaveechai Vachirayonstien
Sep 26, 2013·Therapeutic Drug Monitoring·Laure ElensRon H N van Schaik
May 3, 2018·Expert Opinion on Drug Metabolism & Toxicology·Masataka Nakano, Miki Nakajima
Jan 23, 2020·International Journal of Molecular Sciences·Olubadewa A Fatunde, Sherry-Ann Brown
Jan 18, 2013·Pharmacogenetics and Genomics·Laure ElensRon H N van Schaik
Apr 14, 2016·The Journal of Steroid Biochemistry and Molecular Biology·Fabian Z BurkhardAmit V Pandey
Nov 7, 2019·Toxicological Sciences : an Official Journal of the Society of Toxicology·Liang DingXinxin Ding

Related Concepts

Cytochrome P-450 Oxygenase
Pharmaceutical Preparations
Microsomes, Liver
Incidence Studies
Homologous Sequences, Amino Acid
Single Nucleotide Polymorphism

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Laryngeal Neoplasms

Laryngeal Neoplasms occur in the Larynx and are typically associated with smoking and alcohol consumption. Discover the latest research on Laryngeal Neoplasms here.

Cell Atlas Along the Gut-Brain Axis

Profiling cells along the gut-brain axis at the single cell level will provide unique information for each cell type, a three-dimensional map of how cell types work together to form tissues, and insights into how changes in the map underlie health and disease of the GI system and its crosstalk with the brain. Disocver the latest research on single cell analysis of the gut-brain axis here.